# Kemukus (Piper cubeba)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/kemukus
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Southeast Asian
**Also Known As:** Piper cubeba, Cubeb pepper, Java pepper, Tailed pepper, Kabab chini, Kumkuma, Lada berekor, Cubeba

## Overview

Kemukus (Piper cubeba) contains sabinene (50%) and β-cubebene (18.3%) as primary bioactive compounds with demonstrated [antioxidant activity](/ingredients/condition/antioxidant). The herb provides 45.23 mg GAE/g total phenols in ethanol extracts, though clinical evidence remains limited to laboratory studies.

## Health Benefits

• [Antioxidant](/ingredients/condition/antioxidant) properties from phenolic compounds (45.23 mg GAE/g total phenols in ethanol extracts) - evidence limited to in vitro studies only
• Contains bioactive monoterpenes including sabinene (50%) and sesquiterpenes like β-cubebene (18.3%) - no clinical evidence available
• Rich in lignans such as cubebin and hinokinin - traditional use only, no human studies
• Source of phenylpropanoids including eugenol (33.95%) and methyl eugenol (41.31%) - chemical analysis only
• Traditional Indonesian medicine (Jamu) applications - historical use documented but no clinical validation

## Mechanism of Action

Kemukus exerts antioxidant effects through phenolic compounds that scavenge free radicals and reduce [oxidative stress](/ingredients/condition/antioxidant) markers. The monoterpene sabinene and sesquiterpene β-cubebene contribute to cellular protection by modulating antioxidant enzyme systems. Lignans present in the extract may provide additional cytoprotective mechanisms through anti-[inflammatory pathway](/ingredients/condition/inflammation)s.

## Clinical Summary

Current evidence for kemukus is limited to in vitro laboratory studies demonstrating antioxidant capacity. No human clinical trials or animal studies have been published to establish therapeutic efficacy or safety profiles. The [antioxidant activity](/ingredients/condition/antioxidant) measured at 45.23 mg GAE/g total phenols represents preliminary screening data only. Clinical research is needed to validate traditional uses and determine appropriate dosing protocols.

## Nutritional Profile

{"macronutrients": {"fiber": "High content, specific quantity not well-documented", "protein": "Low content, specific quantity not well-documented"}, "micronutrients": {"vitamins": "Limited data, specific vitamins not well-documented", "minerals": "Limited data, specific minerals not well-documented"}, "bioactive_compounds": {"phenolic_compounds": "45.23 mg GAE/g total phenols in ethanol extracts", "monoterpenes": {"sabinene": "Approximately 50% of total monoterpenes"}, "sesquiterpenes": {"\u03b2-cubebene": "Approximately 18.3% of total sesquiterpenes"}, "lignans": {"cubebin": "Present, specific quantity not well-documented", "hinokinin": "Present, specific quantity not well-documented"}, "phenylpropanoids": "Present, specific compounds and quantities not well-documented"}, "bioavailability_notes": "Limited data available; most studies are in vitro or traditional use with no clinical evidence"}

## Dosage & Preparation

No clinically studied dosage ranges are available as human trials are absent. Extraction studies used 96% ethanol yielding 45.23 mg GAE/g total phenols and 27.85 mg QE/g flavonoids, but no standardization or clinical dosing has been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for kemukus supplementation is extremely limited due to lack of clinical studies. As a member of the Piper genus, potential interactions with cytochrome P450 enzymes may occur, affecting drug [metabolism](/ingredients/condition/weight-management). Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with bleeding disorders should exercise caution as some Piper species may affect coagulation pathways.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Piper cubeba. Research is limited to phytochemical profiling, in vitro [antioxidant](/ingredients/condition/antioxidant) assays, and extraction optimization studies, with no PubMed PMIDs or human study details reported in the available sources.

## Historical & Cultural Context

Piper cubeba has been used historically as a spice and medicine in Indonesian and Southeast Asian traditional systems, particularly within Jamu practices. While it has been valued for its aromatic and purported therapeutic properties, specific traditional indications and historical timelines are not detailed in available sources.

## Synergistic Combinations

Black pepper, Long pepper, Ginger, Turmeric, Galangal

## Frequently Asked Questions

### What is the active compound in kemukus?

Kemukus contains sabinene as its primary monoterpene (50% of volatile oils) and β-cubebene as the main sesquiterpene (18.3%). These compounds, along with lignans and phenolic compounds, contribute to its antioxidant properties.

### How much antioxidant activity does kemukus have?

Laboratory analysis shows kemukus ethanol extracts contain 45.23 mg GAE/g total phenolic compounds. However, this represents test-tube antioxidant capacity only, with no clinical studies confirming benefits in humans.

### Is kemukus safe for daily use?

Safety data for kemukus is insufficient due to lack of clinical trials. Potential drug interactions may occur through cytochrome P450 enzyme systems, and pregnant women should avoid use entirely.

### What's the difference between kemukus and regular black pepper?

Kemukus (Piper cubeba) contains sabinene and β-cubebene as primary compounds, while black pepper (Piper nigrum) contains piperine as its main alkaloid. Kemukus has a different volatile oil profile with distinct sesquiterpene content.

### Does kemukus work for inflammation?

While kemukus contains lignans and phenolic compounds that theoretically could reduce inflammation, no clinical studies have tested anti-inflammatory effects in humans. Current evidence is limited to antioxidant activity in laboratory settings only.

### Is kemukus safe to take during pregnancy or while breastfeeding?

There are no clinical studies evaluating the safety of kemukus supplementation during pregnancy or breastfeeding, making it prudent to avoid use during these periods. Traditional use alone does not provide adequate safety evidence for vulnerable populations. Pregnant and nursing women should consult their healthcare provider before using kemukus supplements.

### Does kemukus interact with common medications like blood thinners or diabetes drugs?

No formal drug interaction studies have been conducted on kemukus with pharmaceutical medications. However, its volatile oil and phenolic content theoretically could affect drug metabolism, particularly with medications processed by the liver. Anyone taking prescription medications should consult their healthcare provider before adding kemukus supplementation.

### What does the scientific evidence actually show about kemukus effectiveness in humans?

Most research on kemukus comes from laboratory (in vitro) studies showing antioxidant and antimicrobial properties, but clinical trials in humans are extremely limited or absent. The majority of evidence is based on traditional use rather than rigorous human studies. Current scientific support is primarily preliminary, and more controlled clinical research is needed to confirm health benefits in people.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*